Identification of SNPs associated with hyperlipidemia, dyslipidemia and defective carbohydrate metabolism

Details for Australian Patent Application No. 2005212831 (hide)

Owner National Public Health Institute

Inventors Pajukanta, Paivi; Peltonen-Palotie, Leena; Taskinen, Marja-Riita; Ehnholm, Christian

Agent Shelston IP

Pub. Number AU-A-2005212831

PCT Pub. Number WO2005/077974

Priority 04003554.5 17.02.04 EP

Filing date 17 February 2005

Wipo publication date 25 August 2005

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

28 September 2006 PCT application entered the National Phase

  PCT publication WO2005/077974 Priority application(s): WO2005/077974

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212832-7H-pyrrolopyrimidine derivatives

2005212830-Less immunogenic binding molecules